Ng C - Search Results

1

Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis.

Marsh R, Santos CD, Yule A, Dellschaft NS, Hoad CL, Ng C, Major G, Smyth AR, Rivett D, van der Gast C. Marsh R, et al. Among authors: ng c. J Cyst Fibros. 2024 Sep;23(5):967-976. doi: 10.1016/j.jcf.2024.05.002. Epub 2024 May 14. J Cyst Fibros. 2024. PMID: 38749891 Free article.

2

Smoking ban in cars protects children, but is vaping 'The Elephant in the Car'?

Ng C, Smyth AR. Ng C, et al. Thorax. 2020 Apr;75(4):297. doi: 10.1136/thoraxjnl-2020-214660. Thorax. 2020. PMID: 32220981 No abstract available.

3

Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging.

Ng C, Dellschaft NS, Hoad CL, Marciani L, Ban L, Prayle AP, Barr HL, Jaudszus A, Mainz JG, Spiller RC, Gowland P, Major G, Smyth AR. Ng C, et al. J Cyst Fibros. 2021 Jul;20(4):591-597. doi: 10.1016/j.jcf.2020.06.004. Epub 2020 Jun 16. J Cyst Fibros. 2021. PMID: 32561324 Free article.

4

Treatment of pulmonary exacerbations in cystic fibrosis.

Ng C, Nadig T, Smyth AR, Flume P. Ng C, et al. Curr Opin Pulm Med. 2020 Nov;26(6):679-684. doi: 10.1097/MCP.0000000000000730. Curr Opin Pulm Med. 2020. PMID: 32890021 Free PMC article. Review.

5

How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey.

Smith S, Rowbotham N, Davies G, Gathercole K, Collins SJ, Elliott Z, Herbert S, Allen L, Ng C, Smyth A. Smith S, et al. Among authors: ng c. BMJ Open Respir Res. 2020 Sep;7(1):e000614. doi: 10.1136/bmjresp-2020-000614. BMJ Open Respir Res. 2020. PMID: 32900780 Free PMC article.

6

Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.

Ng C, Major G, Smyth AR. Ng C, et al. Cochrane Database Syst Rev. 2021 Aug 2;8(8):CD013488. doi: 10.1002/14651858.CD013488.pub2. Cochrane Database Syst Rev. 2021. PMID: 34339047 Free PMC article. Review.

7

A systematic Cochrane Review of the timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.

Ng C, Major G, Smyth AR. Ng C, et al. Paediatr Respir Rev. 2021 Dec;40:44-45. doi: 10.1016/j.prrv.2021.09.002. Epub 2021 Sep 16. Paediatr Respir Rev. 2021. PMID: 34635420 Review. No abstract available.

8

Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis.

Marsh R, Gavillet H, Hanson L, Ng C, Mitchell-Whyte M, Major G, Smyth AR, Rivett D, van der Gast C. Marsh R, et al. Among authors: ng c. J Cyst Fibros. 2022 May;21(3):506-513. doi: 10.1016/j.jcf.2021.11.014. Epub 2021 Dec 8. J Cyst Fibros. 2022. PMID: 34895838 Free article.

9

Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls.

Dellschaft NS, Ng C, Hoad C, Marciani L, Spiller R, Stewart I, Menys A, Barr H, Gowland PA, Major G, Smyth AR. Dellschaft NS, et al. Among authors: ng c. J Cyst Fibros. 2022 May;21(3):502-505. doi: 10.1016/j.jcf.2021.12.007. Epub 2021 Dec 23. J Cyst Fibros. 2022. PMID: 34922853 Free article.

10

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.

Marsh R, Dos Santos C, Hanson L, Ng C, Major G, Smyth AR, Rivett D, van der Gast C. Marsh R, et al. Among authors: ng c. Microbiol Spectr. 2023 Aug 21;11(5):e0117523. doi: 10.1128/spectrum.01175-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37607068 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,163 results

Search Page

Filters